Status:
RECRUITING
Efficacy and Safety of Ultrapulse Carbon Dioxide Laser Treatment in Eyelid Tumors
Lead Sponsor:
Sun Yat-sen University
Conditions:
Eyelid Tumor
Xanthelasma Palpebrarum
Eligibility:
All Genders
18-80 years
Brief Summary
This study aims to assess the long-term efficacy and safety of ultrapulse carbon dioxide (CO₂) laser excision in the treatment of eyelid tumors, including xanthelasma, pigmented nevi, keratoses, and s...
Detailed Description
-Background: The assessment of the efficacy and safety of Ultrapulse CO₂ laser in treating eyelid lesions is crucial for clinical applications. This study aims to evaluate the effectiveness of super-p...
Eligibility Criteria
Inclusion
- Clinically diagnosed with eyelid lesions, including xanthelasma, pigmented nevi, keratoses, and so on.
- No history of photosensitivity, bleeding, or coagulation disorders
- Willing to attend follow-up appointments as scheduled
Exclusion
- Presence of infection in the target area
- Allergy to lidocaine
- Keloid-prone or poor skin repair ability
- Pregnant or lactating
- Recent history of severe infectious diseases, active skin diseases, or major diseases affecting the cardiovascular, liver, kidney, endocrine, and hematopoietic systems
- History of malignant tumors or immune system disorders
Key Trial Info
Start Date :
November 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2025
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT06206681
Start Date
November 1 2022
End Date
September 1 2025
Last Update
March 7 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sun Yat-sen University
Guanzhou, China